Manufacturers’ interest in the development of digital care applications (DiPAs) appears to be low. Only six DiPA consultations at the BfArM will take place shortly. In contrast to DiGA, DiPA requires proof of benefit to be provided immediately upon application – not one year after listing. This means a great deal of effort for a corresponding quantitative comparative study that proves that the benefits of using DIPA are greater than not using it. The health insurance fund will then only pay a maximum of EUR 50 per month for DiPA per person in need of care, regardless of whether they use one or more DiPAs. Anne Geier, Managing Director of the Central Association for Digital Healthcare, considers improvements to the process to be appropriate.
LINK